DCK and acute lymphoblastic leukemia: To directly verify the involvement of DCK in the antileukemic activity of Ara‐C in BCP‐ALL, we tried to knockout DCK expression by a genome editing procedure using a CRSIPR‐Cas9 system 14, 15 in KOPN41, an Ara‐C‐sensitive cell line with high DCK expression.